Navamedic ASA: Amendments to loan agreements with Observe Medical ASA

Published: 15.11.2024

Navamedic ASA: Mandatory notice of trade

Published: 06.11.2024

Navamedic launches Eroxon[®] in Finland

Published: 06.11.2024

Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business

Published: 31.10.2024

Navamedic ASA: Invitation to 2024 3rd quarter presentation

Published: 28.10.2024

Navamedic wins joint Nordic antibiotics tender

Published: 07.10.2024